Nuclear and mitochondrial DNA mutation in human and canine tumors

• Autorzy: Slaska B. , Grzybowska-Szatkowska L. , Bugno-Poniewierska M. , Surdyka M. , Smiech A.
• Języki publikacji: EN

Abstrakty

EN

Over the past few years, there has been a significant progress in genetic testing in dogs through the development of genomic maps, which make it possible to determine the background of polygenic genetic diseases. The information obtained by mapping the canine genome, a detailed marker map, and the understanding of genome architecture have changed the possibilities and direction of canine genetic research. It is now possible to understand the genomics of the qualitative and quantitative traits associated with the phenotype, genetic predisposition, and genetic background of canine defects and diseases. Investigations of canine genetic diseases are particularly valuable because their results can be used in human medicine. From the medical point of view, genetic diseases in both humans and dogs are similar, which makes it possible to test new therapeutic approaches in the case of orthologous genes containing mutations responsible for genetic disorders.

• Wydawca: -
• Czasopismo: Medycyna Weterynaryjna
• Rocznik: 2013
• Tom: 69
• Numer: 04
• Opis fizyczny: p.195-202,ref.

Twórcy

autor

Slaska B.

• Department of Biological Bases of Animal Production, Faculty of Animal Breeding and Biology University of Life Sciences in Lublin, Akademicka 13, 20-950 Lublin, Poland

autor

Grzybowska-Szatkowska L.

• Department of Oncology, Medical University of Lublin, Jaczewskiego 7, 20-090 Lublin, Poland

autor

Bugno-Poniewierska M.

• Laboratory of Genomics, National Research Institute of Animal Production, Krakowska 1, 32-083 Balice, Poland
• Department of Genetics, University of Rzeszow, Rejtana 16C, 35-959 Rzeszow, Poland

autor

Surdyka M.

• Department of Biological Bases of Animal Production, Faculty of Animal Breeding and Biology University of Life Sciences in Lublin, Akademicka 13, 20-950 Lublin, Poland

autor

Smiech A.

• Department of Pathological Anatomy, Faculty of Veterinary Medicine, University of Life Sciences in Lublin, Gleboka 30, 20-612 Lublin, Poland

Bibliografia

• 1.Bemelmans I., Küry S., Albaric O., Hordeaux J., Bertrand L., Nguyen F., Abadie J.: Colorectal hamartomatous polyposis and ganglioneuromatosis in a dog. Vet. Pathol. 2011, 48, 1012-1015.
• 2.Bergman A., Karlsson P., Berggren J., Martinsson T., Bjorck K., Nilsson S., Wahlstrom J., Wallgren A., Nordling M.: Genomewide linkage scan for breast cancer susceptibility loci in Swedish hereditary non-BRCA1/2 families: suggestive linkage to 10q23.32–q25.3. Gene Chromosome Canc. 2007, 46, 302-309.
• 3.Bertagnolli A. C., Sores P., van Asch B., Amorim A., Cirnes L., Maximo V., Cassali G. D.: An assessment of the clonality of the components of canine mixed mammary tumors by mitochondrial DNA analysis. Vet. J. 2009, 182, 269-274.
• 4.Cohen D., Reif J. S., Brodey R. S., Keiser H.: Epidemiological analysis of the most prevalent sites and types of canine neoplasia observed in a veterinary hospital. Cancer Res. 1974, 34, 2859-2868.
• 5.Cullen J. M., Page R., Misdorp W.: An Overview of Cancer, Pathogensis, Diagnosis and Management, [in:] Meuten D. J. (eds.): Tumors in Domestic Animals. Fourth Edition, Iowa State Press. A Blackwell Publishing Company 2002, pp 3-44.
• 6.Czarnecka A. M., Golik P., Bartnik E.: Mitochondrial DNA mutations in human neoplasia. J. Appl. Genet. 2006, 47, 67-78.
• 7.Dasgupta S., Hoque M. O., Upadhyay S., Sidransky D.: Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res. 2008, 3, 700-706.
• 8.Dunlop M. G., Farrington S. M., Carothers A. D., Wyllie A. H., Sharp L., Burn J., Liu B., Kinzler K. W., Vogelstein B.: Cancer risk associated with germline DNA mismatch repair gene mutations. Hum. Molec. Genet. 1997, 6, 105-110.
• 9.Easton D. F., Pooley K. A., Dunning A. M., Pharoah P. D., Thompson D., Ballinger D. G., Struewing J. P., Morrison J., Field H., Luben R., Wareham N., Ahmed S., Healey C. S., Bowman R., Meyer K. B. et al.: Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 2007, 447, 1087-1093.
• 10.Egenvall A., Bonnett B. N., Ohagen P., Olson P., Hedhammar A., von Euler H.: Incidence of and survival after mammary tumors in a population of over 80,000 insured female dogs in Sweden from 1995 to 2002. Prev. Vet. Med. 2005, 69, 109-127.
• 11.Euler H. von, Khoshnoud R., He Q., Khoshnoud A., Fornander T., Rutqvist L. E., Skog S.: Time-dependent RNA degradation affecting cDNA array quality in spontaneous canine tumours sampled using standard surgical procedures. Int. J. Mol. Med. 2005, 16, 979-985.
• 12.Fliss M. S., Usadel H., Caballero O. L., Wu L., Buta M. R., Eleff S. M., Jen J., Sidransky D.: Facile Detection of Mitochondrial DNA Mutations in Tumors and Bodily Fluids. Sciences 2000, 287, 2017-2019.
• 13.Goodstadt L., Ponting C. P.: Phylogenetic reconstruction of orthology, paralogy, and conserved synteny for dog and human. PLoS Comput. Biol. 2006, 2, 9, e133.
• 14.Gregory-Bryson E., Bartlett E., Kiupel M., Hayes S., Yuzbasiyan-Gurkan V.: Canine and human gastrointestinal stromal tumors display similar mutations in c-KIT exon 11. BMC Cancer 2010, 10, 559.
• 15.Gresner P., Gromadzinska J., Polanska K., Twardowska E., Jurewicz J., Wasowicz W.: Genetic variability of Xrcc3 and Rad51 modulates the risk of head and neck cancer. Gene. 2012, 504, 166-174.
• 16.Grzybowska-Szatkowska L., Slaska B.: Mitochondrial DNA and carcinogenesis (Review). Mol. Med. Rep. 2012a, 6, 923-930.
• 17.Grzybowska-Szatkowska L., Slaska B.: Polymorphisms in genes encoding mt-tRNA in female breast cancer in Poland. Mitochondr. DNA 2012b, 23, 106-111.
• 18.Hsu W. L., Huang Y. H., Chang T. J., Wong M. L., Chang S. C.: Single nucleotide variation in exon 11 of canine BRCA2 in healthy and cancerous mammary tissue. Vet. J. 2010, 184, 351-356.
• 19.Hunter D. J., Kraft P., Jacobs K. B., Cox D. G., Yeager M., Hankinson S. E., Wacholder S., Wang Z., Welch R., Hutchinson A., Wang J., Yu K., Chatterjee N., Orr N., Willett W. C., Colditz G. A., Ziegler R. G., Berg C. D. et al.: A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer. Nat. Genet. 2007, 39, 870-874.
• 20.Karlsson E. K., Baranowska I.,Wade C. M., Salmon Hillbertz N. H., Zody M. C., Anderson N., Biagi T. M., Patterson N., Pielberg G. R., Kulbokas E. J. 3rd, Comstock K. E., Keller E. T., Mesirov J. P., von Euler H., Kampe O., Hedhammar A., Lander E. S., Andersson G., Andersson L., Lindblad-Toh K.: Efficient mapping of mendelian traits in dogs through genome-wide association. Nat. Genet. 2007, 39, 1321-1328.
• 21.Kim K. S., Lee S. E., Jeong H. W., Ha J. H.: The complete nucleotide sequence of the domestic dog (Canis familiaris) mitochondrial genome. Molecular Phylogenetics and Evolution. 1998, 10, 210-220.
• 22.Klopfleisch R., Gruber A. D.: Increased expression of BRCA2 and RAD51 in lymph node metastases of canine mammary adenocarcinomas. Vet. Pathol. 2009, 46, 416-422.
• 23.Klopfleisch R., Schutze M., Gruber A. D.: RAD51 protein expression is increased in canine mammary carcinomas. Vet. Pathol. 2010, 47, 98-101.
• 24.Lindblad-Toh K., Wade C. M., Mikkelsen T. S., Karlsson E. K., Jaffe D. B., Kamal M., Clamp M., Chang J. L., Kulbokas E. J. 3rd, Zody M. C., Mauceli E., Xie X., Breen M., Wayne R. K., Ostrander E. A. et al.: Genome sequence, comparative analysis and haplotype structure of the domestic dog. Nature 2005, 438, 803-819.
• 25.Lingaas F., Comstock K. E., Kirkness E. F., Sørensen A., Aarskaug T., Hitte C., Nickerson M. L., Moe L., Schmidt L. S., Thomas R., Breen M., Galibert F., Zbar B., Ostrander E. A.: A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. Hum. Mol. Genet. 2003, 12, 3043-3053.
• 26.Lynch H. T., Smyrk T.: Hereditary nonpolyposis colorectal cancer (Lynch syndrome). An updated review. Cancer 1996, 15, 78(6), 1149-1167.
• 27.Miki Y., Swensen J., Shattuck-Eidens D., Futreal P. A., Harshman K., Tavtigian S., Liu Q., Cochran C., Bennett L. M., Ding W., Bell R., Rosenthal J., Hussey C., Tran T., McClure M., Frye C., Hattier T., Phelps R., Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D., Stone S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P., Narod S., Bristow P. K., Norris F. H., Helvering L., Morrison P., Rosteck P., Lai M., Barrett J.C., Lewis C., Neuhausen S., Cannon-Albright L., Goldgar D., Wiseman R., Kamb A., Skolnick M. H.: A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994, 266, 66-71.
• 28.Munday J. S., French A. F., Gibson I. R., Gwynne K.: Widespread mismatch repair protein expression in canine cutaneous mast cell tumors. Vet. Pathol. 2009, 46, 227-232.
• 29.Murgia C., Pritchard J., Kim S. Y., Fassati A., Weiss R. A.: Clonal Origin and Evolution of Transmissible Cancer. Cell 2006, 126, 478-488.
• 30.Neuman H. P. H., Zbar B.: Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int. 1997, 51, 16-26.
• 31.Parrella P., Yan Xiao Y., Fliss M. et al.: Detection of Mitochondrial DNA Mutations in Primary Breast Cancer and Fine-Needle Aspirates. Cancer Research. 2001, 61, 7623-7626.

Uwagi

Rekord w opracowaniu